Navigation Links
MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
Date:3/26/2009

MedClean to Offer RMW Solutions to MedAssets' GPO Customer Hospitals

BETHEL, Conn., March 26 /PRNewswire-FirstCall/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN), a provider of innovative technology and services for onsite treatment and disposal of regulated medical waste (RMW), today announced that its RMW solutions, including its flagship MedClean(R) Series Systems, has been awarded a contract by MedAssets Supply Chain Systems, a leading group purchasing organization. The MedClean Series System is a turnkey RMW solution for customer hospitals and hospital networks to manage RMW and the destruction of confidential documents.

MedAssets Supply Chain Systems is one of the nation's largest group purchasing organizations (GPOs) providing innovative solutions for healthcare providers to improve their margins and cash flow. MedAssets awards vendor contracts based on extensive criteria including product quality and customer service. The terms of the contract make the MedClean Series immediately available to MedAssets' hospital and IDN GPO customers.

"We are excited to collaborate with MedAssets and believe that the relationship with this leading GPO will enable us to provide our proven MedClean solutions to an expanding base of potential hospital customers," said Scott Grisanti, President and CEO of MedClean Technologies, Inc. "We are proud that our solution meets the rigorous requirements of MedAssets and excited to help MedAssets' customers meet their regulatory requirements for processing RMW and the destruction of confidential documents, while simultaneously helping these customers to reduce their expenses, minimize liability and protect the environment. This unique relationship expands our market reach. We look forward to a long and mutually productive relationship."

Mark Miriani, president of MedAssets Supply Chain Systems added, "MedClean's on-demand, containerized solutions, along with a variety of acquisition options, including purchase and lease, provide an excellent opportunity for our customers to achieve best practices in RMW handling and confidential document destruction. We are excited to deliver this new and significant value to our customers through our relationship with MedClean."

MedClean(R) Series Systems deliver proven ability to treat and dispose of RMW and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner, lowering costs and reducing risk for hospitals and providing a superior alternative to other on-site technologies and outsourced hauling. A single MedClean on-demand container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

About MedAssets Supply Chain Systems, LLC

MedAssets (Nasdaq: MDAS) partners with healthcare providers to improve their financial strength by implementing integrated spend management and revenue cycle solutions that help control cost, improve margins and cash flow, increase regulatory compliance, and optimize operational efficiency. MedAssets serves more than 125 health systems, 3,300 hospitals and 30,000 non-acute care healthcare providers. For more information, visit www.medassets.com.

About MedClean Technologies, Inc.

MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.

Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.

    Contacts:
    MedClean Technologies, Inc.               Investor Contact:
    Kevin Dunphy                              Cameron Donahue
    Chief Financial Officer                   Hayden IR
    (203) 798-1080                            (651) 653-1854
    kdunphy@medcleantechnologies.com          cameron@haydenir.com


'/>"/>
SOURCE MedClean Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedClean Technologies, Inc. Announces $1 Million Order
2. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
3. MedClean Technologies Inc. Announces New Ticker Symbol
4. Meditor Pharmaceuticals (North American) Ltd. announces the closing of a merger agreement with American Medical Technologies, Inc.
5. Patient Safety Technologies, Inc. Announces the Adoption of the Safety-Sponge(TM) System by the First Hospital in the State of Indiana
6. ReBuilder Medical Technologies, Inc. to Change Name to American Med Tech
7. ReBuilder Medical Technologies, Inc. (RBRM) Announces Sales Increase In Jan. 09
8. Scribe Healthcare Technologies, LLC to Integrate BenchMark KB™ in Scribe Complete™ Medical Documentation Platform
9. VirtualHealth Technologies, Inc. Unveils Strategy to Leverage $20 Billion Federal Health IT Proposal
10. Allen Technologies, Inc. Announces Vigo Interactive Communication and Education System Agreement with Saint John's Health Center, Santa Monica, California
11. VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... California, committed to raising awareness for Duchenne muscular dystrophy, and funding for ... CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... The doctors ... Richmond, BC, who live with dental fear and require sedation to receive dental care. ... at ease during various procedures, from hygienic cleanings to oral surgery, at their dental ...
(Date:4/25/2017)... ... 25, 2017 , ... Patients who would like to straighten ... fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, an ... this revolutionary treatment with or without a referral. , Wilckodontics is also ...
(Date:4/25/2017)... ... 25, 2017 , ... As Spring reignites vigilance against Zika ... to Zika virus during pregnancy, as well as other prenatal exposures like cocaine, ... , The Teratology Society is an international and multidisciplinary group of ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., a ... drug prescribing process, today announced it closed $25 million in ... venture capital firm based in Seattle ... Venture Partners . The Series B round included participation from ... in 2014, and GV (formerly Google Ventures). As ...
Breaking Medicine Technology: